PUBLICATION

In vivo targeted and deterministic single-cell malignant transformation

Authors
Scerbo, P., Tisserand, B., Delagrange, M., Debare, H., Bensimon, D., Ducos, B.
ID
ZDB-PUB-250326-2
Date
2025
Source
eLIFE   13: (Journal)
Registered Authors
Bensimon, David, Ducos, Bertrand
Keywords
Danio rerio, cancer, cancer biology, optogenetics, zebrafish
MeSH Terms
  • Zebrafish*
  • Cell Transformation, Neoplastic*/genetics
  • Single-Cell Analysis
  • Animals
  • Optogenetics
  • Brain/pathology
PubMed
40130618 Full text @ Elife
Abstract
Why does a normal cell possibly harboring genetic mutations in oncogene or tumor suppressor genes becomes malignant and develops a tumor is a subject of intense debate. Various theories have been proposed but their experimental test has been hampered by the unpredictable and improbable malignant transformation of single cells. Here, using an optogenetic approach we permanently turn on an oncogene (KRASG12V) in a single cell of a zebrafish brain that, only in synergy with the transient co-activation of a reprogramming factor (VENTX/NANOG/OCT4), undergoes a deterministic malignant transition and robustly and reproducibly develops within 6 days into a full-blown tumor. The controlled way in which a single cell can thus be manipulated to give rise to cancer lends support to the 'ground state theory of cancer initiation' through 'short-range dispersal' of the first malignant cells preceding tumor growth.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping